![]() ![]() ![]() En la mayoría de los casos es transitoria y reversible, aunque provoca un aumento de la morbimortalidad intrahospitalaria en. La nefropatía inducida por el contraste es la reacción adversa más importante. In patients undergoing percutaneous cardiovascular procedures, RenalGuard was associated with a reduced risk of CA-AKI and acute pulmonary edema compared with standard periprocedural hydration strategies.Īcute kidney injury Angiografía coronaria Angioplastia Contrast media Coronary angiography Lesión renal aguda Medios de contraste yodado Nefropatía inducida por contraste Percutaneous coronary intervention.Ĭopyright © 2023. Los medios de contraste yodados son ampliamente utilizados en los Servicios de Radiología con muy baja tasa de efectos adversos. These results were consistent in multiple sensitivity analyses. The Bayesian analysis also showed that RenalGuard had a high probability of ranking first for all the secondary outcomes. La inyeccin se hace en una vena, generalmente en la flexura del codo, mediante bomba de inyeccin conectada a la va. Las reacciones de hipersensibilidad in-mediata son ms frecuentes con contrastes inicos y las no inmediatas estn inducidas esencialmente por no inicos. El contraste iodado intravenoso son medicamentos que se inyectan en el sistema circulatorio durante la realizacin de algunos estudios radiolgicos (TAC y urografas intravenosas principalmente). No significant differences were observed for the other secondary endpoints. El haber presentado una reaccin previa con un contraste yodado (es el principal factor de riesgo). RenalGuard was associated with a significant relative reduction in CA-AKI (median RR, 0.54 95%CrI, 0.31-0.86) and acute pulmonary edema (median RR, 0.35 95%CrI, 0.12-0.87). A Bayesian random-effect risk ratio (RR) with corresponding 95% credibility interval (95%CrI) was calculated for each outcome. Secondary outcomes were all-cause death, cardiogenic shock, acute pulmonary edema, and renal failure requiring renal replacement therapy. We searched Medline, Cochrane Library and Web of Science for randomized trials of RenalGuard vs standard periprocedural hydration strategies. We used a Bayesian framework to perform a meta-analysis of RenalGuard as a CA-AKI preventive strategy. The evidence on RenalGuard in patients undergoing percutaneous cardiovascular procedures is sparse. RenalGuard, which provides real-time matching of intravenous hydration with furosemide-induced diuresis, is an alternative to standard periprocedural hydration strategies. Contrast-associated acute kidney injury (CA-AKI) is a potential complication of procedures requiring administration of iodinated contrast medium.
0 Comments
Leave a Reply. |